PF-Atlas › Mechanisms › AAV-TERT restores telomere length in AEC2s — addresses genetic root cause

AAV-TERT restores telomere length in AEC2s — addresses genetic root cause in IPF

Mechanism of action · idiopathic pulmonary fibrosis

Overview

AAV-TERT restores telomere length in AEC2s — addresses genetic root cause is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 0 clinical trials acting through this mechanism.

Drugs targeting AAV-TERT restores telomere length in AEC2s — addresses genetic root cause

TERT Gene Therapy

Therapies

TERT Gene Therapy

Medical disclaimer. This is a research summary, not medical advice.